TherapeuticsMD (TXMD) executive compensation, 2025 proxy

Marlan D. Walker, Chief Executive Officer, was paid $759,174 in 2024, down 26% from $1M the year before.

Filed
November 3, 2025
Annual meeting
December 15, 2025
Pay year
2024
Named executives
2
CEO total pay
$759,174-26% vs prior year
CEO pay in equity
33%$250,000 in awards
CEO salary
$500,0002024 base salary
CEO stock awards
$250,000RSUs and PSUs
CEO all other
$9,174Health and welfare benefits
Annual incentive target
50% of salaryWalker employment agreement
Ziegler compensation
$120,000JZ Advisory fixed fee
Termination incentive
1.5x targetQualifying termination benefit

How Walker was paid

$759,174 in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary66%Stock awards33%All other compensation1%

Named executive officers

ExecutiveTotal
Marlan D. WalkerChief Executive Officer$759,174
Joseph ZieglerPrincipal Financial and Accounting Officer$120,000

What changed and why

  • $759K$759,174 was CEO Marlan Walker’s 2024 total compensation, down from $1,019,817 in 2023.
  • $250K$250,000 of Walker’s 2024 compensation was restricted stock and performance restricted stock awards.
  • $500K$500,000 was Walker’s 2024 salary, compared with $476,462 in 2023.
  • 50%50% of salary was Walker’s contractual annual short-term incentive compensation target.
  • $120K$120,000 was Joseph Ziegler’s 2024 compensation under the JZ Advisory services arrangement.
  • 1.5x1.5x target annual incentive compensation was included in Walker’s qualifying termination benefits.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.